迈威生物(688062.SH)：已累计回购1069.46万元股份

Core Viewpoint - Maiwei Biotech (688062.SH) has announced a share buyback program, indicating a commitment to returning value to shareholders through repurchase of shares [1] Summary by Categories Share Buyback Details - As of September 30, 2025, the company has repurchased a total of 202,138 shares, which represents 0.05% of the total share capital [1] - The highest price paid for the repurchased shares was RMB 58.02 per share, while the lowest price was RMB 50.00 per share [1] - The total amount spent on the buyback was RMB 10.6946 million, excluding transaction fees such as stamp duty and trading commissions [1]